Skip to main content

Table 2 Summary of robustness studies

From: Stability indicating thin-layer chromatographic method for estimation of antidiabetic drug Remogliflozin etabonate

Method/parameter condition

Normal conditions

Normal Rf value

Deliberate changes

Rf ± S.D. (n = 3)

Effect on drug spot

Mobile phase ratio (Methanol: ethyl acetate: toluene: ammonia, v/v/v)

2:4:4:0.1

0.61

2:4.5:3.5:0.1

0.64 ± 0.01

Compact band

2:3.5:4.5:0.1

0.59 ± 0.03

Compact band

Chamber saturation time (min)

30

25

0.62 ± 0.01

Compact band

35

0.63 ± 0.02

Compact band

Migration distance (mm)

80

85

0.61 ± 0.01

Compact band

75

0.62 ± 0.02

Compact band